PUL01.02 AcceleRET Lung: A Phase 3 Study of First-Line Pralsetinib in Patients with RET-Fusion+ Advanced/Metastatic NSCLC

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2021-01, Vol.16 (1), p.S44-S45
Main Authors: Besse, B., Felip, E., Kim, E.S., Clifford, C., Louie-Gao, M., Yagui-Beltran, A., Popat, S.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2020.10.087